Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease | Open Heart

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Topic collection
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Coronary artery disease

Original research

Intensified lipid-lowering treatment with alirocumab in patients with coronary heart disease

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

	Abstract	Full	Pdf
May 2021	328	334	132
Jun 2021	135	129	42
Jul 2021	60	60	11
Aug 2021	57	54	18
Sep 2021	83	82	32
Oct 2021	68	66	38
Nov 2021	39	38	26
Dec 2021	46	44	28
Jan 2022	56	55	25
Feb 2022	40	40	21
Mar 2022	53	55	30
Apr 2022	53	56	27
May 2022	42	39	31
Jun 2022	41	41	20
Jul 2022	27	26	9
Aug 2022	42	43	18
Sep 2022	38	38	26
Oct 2022	43	43	24
Nov 2022	37	35	16
Dec 2022	23	23	4
Jan 2023	36	37	12
Feb 2023	62	64	17
Mar 2023	31	32	8
Apr 2023	37	36	17
May 2023	76	77	19
Jun 2023	17	17	8
Jul 2023	35	35	17
Aug 2023	35	34	15
Sep 2023	24	24	4
Oct 2023	26	31	17
Nov 2023	34	34	13
Dec 2023	42	35	13
Jan 2024	37	37	15
Feb 2024	25	26	14
Mar 2024	33	33	32
Total	1861	1853	799